Skip to main content
Equibles

Dr. Ralph Schiess

CEO

Onconetix, Inc. (ONCO)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Dr. Ralph Schiess

Dr. Ralph Schiess is recorded as CEO at Onconetix, Inc. (ONCO). Onconetix, Inc. reported in an 8-K filed February 28, 2025 that Dr. Ralph Schiess resigned as Chief Science Officer, effective February 24, 2025. Onconetix, Inc. reported in an 8-K filed February 28, 2025 that Dr. Ralph Schiess resigned as Interim Chief Executive Officer, effective February 24, 2025. Onconetix, Inc. reported in an 8-K filed January 12, 2024 that Dr. Ralph Schiess was appointed Interim Chief Executive Officer, effective January 12, 2024.

“On February 24, 2025, Dr. Ralph Schiess resigned from his positions as the Interim Chief Executive Officer and Chief Science Officer of Onconetix, Inc. (the “Company”), effective immediately, and from his position as Chief Executive Officer of Proteomedix AG, effective May 31, 2025.”
Onconetix, Inc. Form 8-K, filed February 28, 2025 · Read the filing
“On February 24, 2025, Dr. Ralph Schiess resigned from his positions as the Interim Chief Executive Officer and Chief Science Officer of Onconetix, Inc. (the “Company”), effective immediately, and from his position as Chief Executive Officer of Proteomedix AG, effective May 31, 2025.”
Onconetix, Inc. Form 8-K, filed February 28, 2025 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Onconetix, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.